{"id":"W4415963750","doi":"10.51731/cjht.2025.1283","title":"Darolutamide (Nubeqa)","year":2025,"lang":"","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Enzalutamide; Prostate cancer; Androgen deprivation therapy; Abiraterone acetate; Abiraterone; Placebo","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001206207,0.0003871233,0.0006342349,0.001318198,0.0007467901,0.001051012,0.0009415833,0.001065846,0.01910705],"category_scores_gemma":[0.002024531,0.0002009287,0.00067548,0.0009923928,0.0004775278,0.0004909039,0.0007545167,0.002008997,0.004408037],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003913357,"about_ca_system_score_gemma":0.006967606,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.07321434,"about_ca_topic_score_gemma":0.1888691,"domain_scores_codex":[0.9992526,0.0001479389,0.00004766228,0.0001195352,0.0003240315,0.0001081782],"domain_scores_gemma":[0.9992433,0.00009028864,0.0001191624,0.00005257833,0.0003210389,0.0001737758],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002197794,0.0003650341,0.001267001,0.002391307,0.00017143,0.0003945853,0.00009699367,0.0004083882,0.01055544,0.00938586,0.2564109,0.7163553],"study_design_scores_gemma":[0.0009781095,0.0003965412,0.002045836,0.0004527844,0.00005053972,0.0005770205,0.00001923522,0.0001083788,0.002398388,0.0006009527,0.9923569,0.00001531351],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.03098495,0.5898318,0.005935283,0.02291414,0.003739714,0.002105707,0.02151879,0.002050815,0.3209189],"genre_scores_gemma":[0.3889519,0.2530697,0.02182137,0.0334532,0.0009923528,0.001670134,0.03703612,0.0004074775,0.2625977],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.07321434,"threshold_uncertainty_score":0.1455764,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03299168729858459,"score_gpt":0.357982561488245,"score_spread":0.3249908741896604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}